Primary immunodeficiency disease: A model for case management of chronic diseases

Professional Case Management

Volumn 15, Issue 1, 2010, Pages 5-14

  Burton, Janet ^a   Murphy, Elyse ^b   Riley, Patty ^b  

^a NATIONAL HEALTH SERVICE   (United Kingdom)

^b CSL Behring LLC   (United States)

Author keywords

Chronic care management; Primary immunodeficiency disease; Self administered immunoglobulin replacement therapy; Specialist immunology nurse; Subcutaneous immunoglobulin replacement therapy

Indexed keywords

CASE MANAGEMENT; CHRONIC DISEASE; DISEASE MANAGEMENT; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; MODEL; NURSE PATIENT RELATIONSHIP; NURSING; PATIENT CARE; PATIENT PARTICIPATION; REVIEW; UNITED STATES;

CASE MANAGEMENT; CHRONIC DISEASE; DISEASE MANAGEMENT; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INCIDENCE; MODELS, NURSING; NURSE-PATIENT RELATIONS; PATIENT PARTICIPATION; PATIENT-CENTERED CARE; UNITED STATES;

EID: 75149158886     PISSN: 15297764     EISSN: 15390675     Source Type: Journal    
DOI: 10.1097/NCM.0b013e3181b5dec4     Document Type: Article

References (35)

1. Aghamohammadi, A., Mohammadi, J., Parvaneh, N., Rezaei, N., Moin, M., Espanol, T., et al. (2008). Progression of selective IgA deficiency to common variable immunodeficiency. International Archives of Allergy and Immunology, 147(2), 87-92.
2. Aliotta, S., Grieve, K., Giddens, J. F., Dunbar, L., Groves, C., Frey, K., et al. (2008). Guided care: A new frontier for adults with chronic conditions. Professional Case Management, 13(3), 151-158.
3. American Medical Association. (2009). Current procedural terminology: CPT 2008 (pp. 384-385). Atlanta, GA: Ingenix Publishing Group.
4. Berger, M. (2008). Principles of and advances in immunoglobulin replacement for primary immunodeficiency. Immunology and Allergy Clinics of North America, 28(2), 413-437.
5. Borte, M., Oertelt, C., & Hogy, B. (2005). Treatment for patients with primary antibody deficiencies in Germany. Klinische Padiatrie, 217(5), 276-280.
6. Boyle, J. M., & Buckley, R. H. (2007). Population prevalence of diagnosed primary immunodeficiency diseases in the United States. Journal of Clinical Immunology, 27(5), 497-502.
7. Fasth, A., & Nystrom, J. (2008). Quality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulin. Journal of Clinical Immunology, 28(4), 370-378.
8. Fayers, P. M., & Machin, D. (2000). Quality of Life: Assessment, analysis and interpretation (pp. 3-5). Chichester, England: Wiley.
9. Funnell, M. M. (2000). Helping patients take charge of their chronic illness. Retrieved May 12, 2009, from http://www.rncasemanager.com/articles/ HelpingPatients.asp
10. Gallagher, R., Donoghue, J., Chenoweth, L., & Stein-Parbury, J. (2008). Self-management in older patients with chronic illness. International Journal of Nursing Practice, 14(5), 373-382.
11. Gardulf, A., Bjorvell, H., Gustafson, R., Hammarstroom, L., & Smith, C. I. (1993). The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions. Clinical Experimental Immunology, 92(2), 200-203.
12. Gardulf, A., Nicolay, U., Math, D., Asensio, O., Bernatowska, E., Böck, A, et al. (2004). Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home. Journal of Allergy and Clinical Immunology, 114(4), 936-942.
13. Glasgow, R. E., Orleans, C. T., Wagner, E. H., Curry, S. J., & Solberg, L. I. (2001). Does the chronic care model serve as a template for prevention? Milbank Quarterly, 79(4), 579-611.
14. Godwin, Y. (2000). Do they listen? A review of information retained by patients following consent for reduction mammoplasty. British Journal of Plastic Surgery, 53(2), 121-125.
15. Haddad, L., Perrinet, M., Parent, D., Leroy-Cotteau, A., Toguyeni, E., Condette-Wojtasik, G., et al. (2006). Economic evaluation of at home subcutaneous and intravenous immunoglobulin substitution. La Revue de Medecine Interne, 27(12), 924-926.
16. Ho, C., Membe, S., Cimon, K., Roifman, C., Kanani, A., & Morrison, A. (2008). Subcutaneous versus intravenous immunoglobulin for primary immunodeficiencies: Systematic review and economic evaluation (Technology Rep. No. 98). Ottawa, Ontario, Canada: Canadian Agency for Drugs and Technologies in Health.
17. Buckley, R. (Ed.). (2007). IDF Patient & family handbook: For primary immunodeficiency diseases (4th ed.). Towson, MD: Immune Deficiency Foundation.
18. Jeffrey Modell Foundation. (n.d.). Retrieved November 9, 2007, from http://www.info4pi.org/jmf/index.cfm? CFID=35979705&CFTOKEN=29089111
19. Kittner, J. M., Grimbacher, B., Wulff, W., Jäger, B., & Schmidt, R. E. (2006). Patients' attitude to subcutaneous immunoglobulin substitution as home therapy. Journal of Clinical Immunology, 26(4), 400-405.
20. Lindegren, M. L., Kobrynski, L., Rasmussen, S. A., Moore, C. A., Grosse, S. D., Vanderford, M. L., et al. (2004). Applying public health strategies to primary immunodeficiency diseases: A potential approach to genetic disorders. Morbidity and Mortality Weekly Report. Recommendations and Report, 53(RR-01), 1-29.
21. Modell, V. (2007). The impact of physician education and public awareness on early diagnosis of primary immunodeficiencies: Robert A. Good Immunology Symposium. Immunologic Research, 38(1/3), 43-47.
22. National Health Service. (n.d.). The expert patients program. Retrieved November 9, 2007, from www.nhs.uk/Conditions/Expert-Patients-programme-/Pages/ Introduction.aspx
23. National Organization for Rare Diseases. (n.d.). Primary agammaglobulinemias. Retrieved November 9, 2007, from http://www.rarediseases. org/programs/nordresourceguide
24. National Primary Immunodeficiency Resource Center. (n.d.). Primary immunodeficiency diseases. Retrieved November 9, 2007, from http//www.info4pi. org/patienttopatient/index.cfm?section/patienttopatient&content= syndromes& area4&CFID=23085071&CFTKEN=73038
25. Nicolay, U., Keissling, P., Berger, M., Gupta, S., Yel, L., Roifman, C., et al. (2006). Health-related quality of life and treatment satisfaction in North American patients with primary immunodeficiency diseases receiving subcutaneous IgG self-infusions at home. Journal of Clinical Immunology, 26(1), 65-72.
26. Schaefer, J., & Davis, C. (2004). Case management and the chronic care model: A multidisciplinary role. Lippincott's Case Management, 9(2), 96-103.
27. Sidorov, J., Paulick, P., & Sobel, L. (2003). What is the return on investment associated with diabetes disease management? A report from one managed care organization in Pennsylvania, USA. Disease Management & Health Outcomes, 11(9), 565-570.
28. TriCenturion. (2006). Region A DMERC PSC Bulletin June 2006. Retrieved May 12, 2009, from http://tricenturion.com/content/reg-ab-dme-psc-toc.cfm
29. U.S. Census Bureau. (2008a). 2008 population estimates. Retrieved January 12, 2009, from http://factfinder. census.gov/servlet/DatasetMainPageServlet? program= PEP&submenuld=datasets3&lang=en
30. U.S. Census Bureau. (2008b). Age Data of the United States. Retrieved January 12, 2009, from http://www.census.gov/population/www/socdemo/age/general- age.html
31. U.S. Department of Health and Human Services. ( 2009). Medicare DME MAC LCDs: L27215, L5044, L11555, and L11570 (updated 1/1/2009). Retrieved May 12, 2009, from http://www.cms.hhs.gov/transmittals/downloads/R1419CP.pdf
32. Wagner E. H., Austin B. T., & Von Korff, M. (1996a). Improving outcomes in chronic illness. Managed Care Quarterly, 4(2), 12-25.
33. Wagner E. H., Austin B. T., & Von Korff, M. (1996b). Organizing care for patients with chronic illness. Milbank Quarterly, 74(4), 511-544.
34. Wagner, E. H., Davis, C., Schaefer, J., Von Korff, M., & Austin, B. (1999). A survey of leading chronic disease management programs: Are they consistent with the literature? Managed Care Quarterly, 7(3), 56-66.
35. Wood, P., Stanworth, S., Burton, J., Jones, A., Peckham, D. G., Green, T., et al.; on behalf of the UK Primary Immunodeficiency Network. (2007). Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: A systematic review. Clinical Experimental Immunology, 149(3), 410-423.